RecruitingNCT07154134

Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome

Comparative Study Between Endocan and Copeptin Serum Levels in Preterm Neonates With Respiratory Distress Syndrome


Sponsor

Tanta University

Enrollment

40 participants

Start Date

Jul 10, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This work aims to investigate and compare the levels of serum endocan and serum copeptin on the first day of life and correlate their levels to the severity of respiratory distress in preterm neonates suffering from respiratory distress syndrome.


Eligibility

Min Age: 28 WeeksMax Age: 36 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Serum copeptin and Serum endocan for people with copeptin, endocan, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 28 Weeks to 36 Weeks.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTSerum endocan

Serum endocan will be measured by an enzyme-linked immunosorbent assay (ELISA) on the first day of life.

DIAGNOSTIC_TESTSerum copeptin

Serum copeptin will be measured by an enzyme-linked immunosorbent assay (ELISA) on the first day of life.


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07154134


Related Trials